As of Oct 06
| 0.00 / 0.00%|
The 9 analysts offering 12-month price forecasts for Astellas Pharma Inc have a median target of 22.20, with a high estimate of 25.73 and a low estimate of 19.02. The median estimate represents a +68.92% increase from the last price of 13.14.
The current consensus among 9 polled investment analysts is to Buy stock in Astellas Pharma Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.